期刊文献+

Microscopic features of colorectal neoplasia in inflammatory bowel diseases 被引量:5

Microscopic features of colorectal neoplasia in inflammatory bowel diseases
下载PDF
导出
摘要 The risk of developing dysplasia leading to colorectal cancer (CRC) is increased in both ulcerative colitis and Crohn’s disease. The prognosis of CRC may be poorer in patients with inflammatory bowel disease (IBD) than in those without IBD. Most CRCs, in general, develop from a dysplastic precursor lesion. The interpretation by the pathologist of the biopsy will guide decision making in clinical practice: colonoscopic surveillance or surgical management. This review summarizes features of dysplasia (or intraepithelial neoplasia) with macroscopic and microscopic characteristics. From an endoscopic (gross) point of view, dysplasia may be classified as flat or elevated (raised); from a histological point of view, dysplasia is separated into 3 distinct categories: negative for dysplasia, indefinite for dysplasia, and positive for dysplasia with low- or high-grade dysplasia. The morphologic criteria for dysplasia are based on a combination of cytologic (nuclear and cytoplasmic) and architectural aberrations of the crypt epithelium. Immunohistochemical and molecular markers for dysplasia are reviewed and may help with dysplasia diagnosis, although diagnosis is essentially based on morphological criteria. The clinical, epidemiologic, and pathologic characteristics of IBD-related cancers are, in many aspects, different from those that occur sporadically in the general population. Herein, we summarize macroscopic and microscopic features of IBD-related colorectal carcinoma. The risk of developing dysplasia leading to colorectal cancer(CRC)is increased in both ulcerative colitis and Crohn’s disease.The prognosis of CRC may be poorer in patients with inflammatory bowel disease(IBD)than in those without IBD.Most CRCs,in general,develop from a dysplastic precursor lesion.The interpretation by the pathologist of the biopsy will guide decision making in clinical practice:colonoscopic surveillance or surgical management.This review summarizes features of dysplasia(or intraepithelial neoplasia)with macroscopic and microscopic characteristics.From an endoscopic(gross)point of view,dysplasia may be classified as flat or elevated(raised);from a histological point of view,dysplasia is separated into 3 distinct categories:negative for dysplasia,indefinite for dysplasia,and positive for dysplasia with low-or high-grade dysplasia.The morphologic criteria for dysplasia are based on a combination of cytologic(nuclear and cytoplasmic)and architectural aberrations of the crypt epithelium.Immunohistochemical and molecular markers for dysplasia are reviewed and may help with dysplasia diagnosis,although diagnosis is essentially based on morphological criteria.The clinical,epidemiologic,and pathologic characteristics of IBD-related cancers are,in many aspects,different from those that occur sporadically in the general population.Herein,we summarize macroscopic and microscopic features of IBD-related colorectal carcinoma.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第12期3164-3172,共9页 世界胃肠病学杂志(英文版)
关键词 Inflammatory bowel disease DYSPLASIA Colorectal cancer Microscopic features Inflammatory bowel disease Dysplasia Colorectal ca
  • 相关文献

参考文献12

  • 1Jonas Mudter.What's new about inflammatory bowel diseases in 2011[J].World Journal of Gastroenterology,2011,17(27):3177-3177. 被引量:1
  • 2Roberto Grassia,Paolo Bodini,Paolo Dizioli,Teresa Staiano,Elena Iiritano,Guglielmo Bianchi,Federico Buffoli.Neuroendocrine carcinomas arising in ulcerative colitis:Coincidences or possible correlations?[J].World Journal of Gastroenterology,2009,15(33):4193-4195. 被引量:4
  • 3Kathrin Ludwig,Matteo Fassan,Claudia Mescoli,Marco Pizzi,Mariangela Balistreri,Laura Albertoni,Salvatore Pucciarelli,Marco Scarpa,Giacomo Carlo Sturniolo,Imerio Angriman,Massimo Rugge.PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis[J].Virchows Archiv.2013(1)
  • 4Ravi P. Kiran,Pasha J. Nisar,John R. Goldblum,Victor W. Fazio,Feza H. Remzi,Bo Shen,Ian C. Lavery.Dysplasia Associated With Crohn?s Colitis: Segmental Colectomy or More Extended Resection?[J].Annals of Surgery.2012(2)
  • 5Tine Jess,Christine Rungoe,Laurent Peyrin–Biroulet.Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies[J].Clinical Gastroenterology and Hepatology.2012(6)
  • 6Gert Van Assche,Axel Dignass,Bernd Bokemeyer,Silvio Danese,Paolo Gionchetti,Gabriele Moser,Laurent Beaugerie,Fernando Gomollón,Winfried H?user,Klaus Herrlinger,Bas Oldenburg,Julian Panes,Francisco Portela,Gerhard Rogler,Jürgen Stein,Herbert Tilg,Simon Travis,James O. Lindsay.Second European evidence-based consensus on the diagnosis and management of ulcerative colitis: Special situations[J].Journal of Crohn’s and Colitis.2012
  • 7Laurent Peyrin‐Biroulet,C?me Lepage,Valérie Jooste,Jean‐Louis Guéant,Jean Faivre,Anne‐Marie Bouvier.Colorectal cancer in inflammatory bowel diseases: A population‐based study (1976–2008)[J].Inflamm Bowel Dis.2012(12)
  • 8John B.Kisiel,Edward V.Loftus,W. ScottHarmsen,Alan R.Zinsmeister,William J.Sandborn.Outcome of sporadic adenomas and adenoma‐like dysplasia in patients with ulcerative colitis undergoing polypectomy[J].Inflamm Bowel Dis.2012(2)
  • 9Angelamaria Rizzo,Francesco Pallone,Giovanni Monteleone,Massimo Claudio Fantini.Intestinal inflammation and colorectal cancer:A doubleedged sword?[J].World Journal of Gastroenterology,2011,17(26):3092-3100. 被引量:27
  • 10Chun-Chuan Chen,Joel Pekow,Victoria Llado,Manasa Kanneganti,Cindy W. Lau,Atsushi Mizoguchi,Mari Mino-Kenudson,Marc Bissonnette,Emiko Mizoguchi.Chitinase 3-Like-1 Expression in Colonic Epithelial Cells as a Potentially Novel Marker for Colitis-Associated Neoplasia[J].The American Journal of Pathology.2011(3)

二级参考文献12

  • 1Itzkowitz SH,Present DH.Consensus conference:Colorectal cancer screening and surveillance in inflammatory bowel disease.Inflamm Bowel Dis 2005;11:314-321.
  • 2Eaden JA,Mayberry JF.Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.Gut 2002;51 Suppl 5:V10-V12.
  • 3Eaden JA,Abrams KR,Mayberry JF.The risk of colorectal cancer in ulcerative colitis:a meta-analysis.Gut 2001;48:526-535.
  • 4Wong NA,Harrison DJ.Colorectal neoplasia in ulcerative colitis-recent advances.Histopathology 2001;39:221-234.
  • 5Bernick PE,Klimstra DS,Shia J,Minsky B,Saltz L,Shi W,Thaler H,Guillem J,Paty P,Cohen AM,Wong WD.Neuroendocrine carcinomas of the colon and rectum.Dis Colon Rectum 2004;47:163-169.
  • 6Vortmeyer AO,Lubensky IA,Merino MJ,Wang CY,Pham T,Furth EE,Zhuang Z.Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas.J Natl Cancer Inst 1997;89:1448-1453.
  • 7Greenstein AJ,Balasubramanian S,Harpaz N,Rizwan M,Sachar DB.Carcinoid tumor and inflammatory bowel disease:a study of eleven cases and review of the literature.Am J Gastroenterol 1997;92:682-685.
  • 8Sigel JE,Goldblum JR.Neuroendocrine neoplasms arising in inflammatory bowel disease:a report of 14 cases.ModPathol 1998;11:537-542.
  • 9Case records of the Massachusetts General Hospital.Weekly clinicopathological exercises.Case 28-2000.A34-year-old man with ulcerative colitis and a large perirectal mass.N Engl J Med 2000;343:794-800.
  • 10van der Woude CJ,van Dekken H,Kuipers EJ.Bleeding-not always a sign of relapse of long-standing colitis.Endoscopy 2007;39 Suppl 1:E121-E122.

共引文献45

同被引文献13

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部